Prognostic value of paraaortic lymph node metastases in patients with ductal adenocarcinoma of the pancreatic head

Published:December 23, 2022DOI:



      The role of paraaortic lymphadenectomy for cancer of the pancreatic head is controversial. The aim of this study is to analyze the prognostic role of paraaortic lymph node (PALN) metastases after resection for ductal adenocarcinoma of the pancreatic head.

      Materials and methods

      A retrospective analysis of all patients, who underwent upfront resection for ductal adenocarcinoma of the pancreatic head at the Frankfurt University Hospital from 2011 to 2020 was performed. The primary endpoint was survival, according to the presence of PALN metastases.


      Out of 468 patients with pancreatic resection, 148 had an upfront resection for ductal adenocarcinoma. Of those, in 125 (85%) a paraaortic lymphadenectomy was performed. In 19 (15.2%) PALN metastases were detected. The estimated overall median survival after resection was 21.7 months (95% CI 18.8 to 26.4), the disease free survival 16 months (95% CI 12 to 18). Among the patients with lymph node metastases, PALN metastases had no significant influence on overall (18.9 versus 19 months, HR = 1.3, 95% CI 0.7 to 2.6, p = 0.392) or disease free survival (14 versus 10.7 months, HR = 1.7, 95% CI 0.9 to 3.2, p = 0.076). After adjusting for T-stage, N-stage, grade, resection margin, PALN metastases, and adjuvant therapy, only adjuvant therapy had a prognostic significance for overall survival (HR = 0.47, 95% CI 0.26 to 0.85, p = 0.013).


      Patients with ductal adenocarcinoma of the pancreatic head and PALN metastases do not have inferior outcomes than those with regional lymph node metastases. Thus, positive PALN should not be considered a contraindication for resection.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tol J.A.M.G.
        • Gouma D.J.
        • Bassi C.
        • et al.
        Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
        Surgery. 2014; 156: 591-600
      1. Classification of pancreatic carcinoma. Kanehara & Co., Tokyo2017
        • Sho M.
        • Murakami Y.
        • Motoi F.
        • et al.
        Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
        J Gastroenterol. 2015; 50: 694-702
        • Safi S.A.
        • Rehders A.
        • Haeberle L.
        • et al.
        Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: distant neighbors?.
        Surgery. 2021; 170: 1807-1814
        • Sakai M.
        • Nakao A.
        • Kaneko T.
        • et al.
        Para-aortic lymph node metastasis in carcinoma of the head of the pancreas.
        Surgery. 2005; 137: 606-611
        • Schwarz L.
        • Lupinacci R.M.
        • Svrcek M.
        • et al.
        Para-aortic lymph node sampling in pancreatic head adenocarcinoma.
        Br J Surg. 2014; 101: 530-538
        • Nappo G.
        • Borzomati D.
        • Perrone G.
        • et al.
        Incidence and prognostic impact of para-aortic lymph nodes metastases during pancreaticoduodenectomy for peri-ampullary cancer.
        HPB. 2015; 17: 1001-1008
        • Linder S.
        • Holmberg M.
        • Engstrand J.
        • et al.
        Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - time to consider a reclassification?.
        Surg Oncol. 2022; 41101735
        • Sperti C.
        • Gruppo M.
        • Blandamura S.
        • et al.
        Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
        World J Gastroenterol. 2017; 23: 4399
        • Hempel S.
        • Plodeck V.
        • Mierke F.
        • et al.
        Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection.
        (Sci Rep [Internet], [cited 2022 Aug 6];7. Available from:)
        • Doi R.
        • Kami K.
        • Ito D.
        • et al.
        Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.
        World J Surg. 2007; 31: 147-154
      2. Brierley J. Gospodarowicz M.K. Wittekind C. TNM classification of malignant tumours. eighth ed. John Wiley & Sons, Inc, Chichester, West Sussex, UK ; Hoboken, NJ2017
        • van Rijssen L.B.
        • Narwade P.
        • van Huijgevoort N.C.M.
        • et al.
        Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis.
        HPB. 2016; 18: 559-566
        • Connor S.
        • Bosonnet L.
        • Ghaneh P.
        • et al.
        Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status.
        Br J Surg. 2004; 91: 1592-1599
        • Pande R.
        • Chughtai S.
        • Ahuja M.
        • et al.
        Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma.
        World J Gastrointest Surg. 2022; 14: 429-441
        • R Core Team
        R: a language and environment for statistical computing.
        ([Internet]) R Foundation for Statistical Computing, Vienna, Austria2020 (Available from:)
        • Kim J.S.
        • Hwang H.K.
        • Lee W.J.
        • et al.
        Unexpected para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma: a contraindication to resection?.
        J Gastrointest Surg. 2020; 24: 2789-2799
        • Garnier J.
        • Magallon C.
        • Ewald J.
        • et al.
        Intraoperative frozen section analysis of para-aortic lymph nodes after neoadjuvant FOLFIRINOX: will it soon become useless?.
        Langenbeck's Arch Surg. 2022; 407: 1065-1071
        • Pranger B.K.
        • Tseng D.S.J.
        • Ubels S.
        • et al.
        How to approach para-aortic lymph node metastases during exploration for suspected periampullary carcinoma: resection or bypass?.
        Ann Surg Oncol. 2020; 27: 2949-2958